Guillaume Dalmasso
Clermont-ferrand, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Cytotoxic Necrotizing Factor 1-producing E. coli Enhance Colorectal Tumorigenesis in ApcMin/+ Mice With Autophagy Deficiency in Intestinal Epithelial Cells.
Journal: The Journal of infectious diseases
Published: August 09, 2025
Vat-Mediated Mucus Penetration Enables Genotoxic Activity of pks+ Escherichia coli.
Journal: International journal of molecular sciences
Published: April 26, 2025
ATG16L1 in myeloid cells limits colorectal tumor growth in ApcMin/+ mice infected with colibactin-producing Escherichia coli via decreasing inflammasome activation.
Journal: Autophagy
Published: May 31, 2024
The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance.
Journal: Gut microbes
Published: February 28, 2024
Colibactin-producing Escherichia coli enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence.
Journal: Gut microbes
Published: February 20, 2024
Identification of autophagy receptors for the Crohn's disease-associated adherent-invasive Escherichia coli.
Journal: Frontiers in cellular and infection microbiology
Published: July 27, 2023
Correction: Interaction of Saccharomyces boulardii with Salmonella enterica Serovar Typhimurium Protects Mice and Modifies T84 Cell Response to the Infection.
Journal: PloS one
Published: April 11, 2022
Host Colonization as a Major Evolutionary Force Favoring the Diversity and the Emergence of the Worldwide Multidrug-Resistant Escherichia coli ST131.
Journal: mBio
Published: August 24, 2021
Colibactin-Producing Escherichia coli Induce the Formation of Invasive Carcinomas in a Chronic Inflammation-Associated Mouse Model.
Journal: Cancers
Published: April 12, 2021
Last Updated: 09/26/2026